Bonito Biosciences
Building the data foundation for programmable oligonucleotide delivery
Waltham, United States · Founded 2025
- Headquarters
- Waltham, Massachusetts
- Employees
- 1–10
- Founded
- 2025
- Business Model
- B2B
- Website
- bonitobio.com
About
Bonito Biosciences is a biotechnology company building the data foundation for programmable oligonucleotide delivery to any cell or tissue type. The company's platform combines giga-scale encoded molecular libraries with functional live-cell selections and AI-enabled discovery loops to identify highly potent delivery ligands and advance oligotherapeutic payloads. Co-founded by serial entrepreneurs Richard Wagner and Brant Binder, Bonito is addressing one of the most critical challenges in medicine — tissue-selective drug delivery — with applications in RNA interference therapeutics, oncology, and other indications requiring precise cell-specific targeting.
Summary
Bonito Biosciences is a Biotech company based in Waltham, United States, founded in 2025.
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.